|
EVENT
Full-Day Continuing Education Course
Date:
May 29, 2007
Location:
Massachusetts Institute of Technology
Room 10-250 (in Building 10)
Registration:
Registration form (PDF)
Register by May 23 for reduced rate
Agenda:
Course agenda (PDF)
Directions:
Directions to MIT
Map of MIT campus (including workshop location)
Contact:
Dr. Igor Linkov
617-225-0812
ilinkov@intertox.com
Organizers:
Igor Linkov (Society for Risk Analysis/Intertox), Mike Ellenbecker
(Mass. Toxic Use Reduction Institute), and Sam Lipson (Cambridge Public Health Department)
With 300 products in use today, what information is available to demonstrate that nanomaterials do not pose unnecessary risks to human and environmental health? What areas are in need of EHS science? How could risks and environmental impacts of nanomaterials throughout the product life-cycle be minimized with engineering practices to improve product safety and to avoid potential future litigation? Our training course is designed to help you navigate the ever-changing world of nanotechnology.
The day-long training course will cover a diverse range of topics essential for professionals in nanotechnology and biotechnology, with nationally recognized experts from industry, academia, and government leading each topic. Participants will include government regulators, corporate decision makers, and scientists in the field. Topics will include a discussion of the current understanding of nanomaterial risks, EHS state-of-the-practice in companies involved with nanomaterials, a discussion of current and anticipated regulatory developments in the field, a primer on the toxicology of nanomaterials (including ecotoxicological issues), and an assessment of appropriate occupational safety and health practices associated with these technologies.
Participants should expect to gain an awareness of the critical issues in this evolving field and a set of conceptual tools needed to make decisions and prioritize challenges in their own organizations. Nanotechnology is a broad and complex field of research and manufacturing with many discrete decision-points. For example, some decisions might be based upon an ability to predict which nanomaterials will have favorable chemical characteristics and lower toxicities, to identify important knowledge and technology gaps, and to develop effective communication with stakeholders and the general public. This course is intended to facilitate those who must make these decisions in an uncertain environment.
Lectures
Nanotechnology: Current State
T. Earles, Office of Science and Technology Policy, White House
Exposure to Nanomaterials
M. Ellenbecker (Mass Toxic Use Reduction Institute)
Nanomaterial Risk Characterization
K. Kulinowski, International Council on Nanotechnology, Rice University
Ecotoxicology of Nanomaterials
J. Steevens (Army Corps of Engineers)
Life Cycle Assessment of Nanoproducts
J. Isaacs (Northeastern University)
Nanomaterials: Occupational Health and Safety
V. Murashov, NIOSH
NanoSafe: Controlling Exposure in the Workplace
M. Hull (Luna Innovation) and I. Linkov (Intertox)
Nano regulations at City levels: Motivation and Needs
S. Lipson (City of Cambridge)
Nano regulations at City levels: Berkeley Experience
J. Monica (Porter Wright)
Expert Understanding of Nano-Safety: A View from Canada
L. Sheremeta (National Nanotech Institute, Canada)
Managing Nanomaterial EHS Legal Risks: A Practical Approach
J. Votaw (Wilmer and Hale)
NanoRisk Assessment Research Strategy
M. Davis and J. Shatkin (US EPA and Cadmus)
Integrated Life Cycle Approach for Nano Risk Management
D. Karkan (Health Canada)
Linking Risk Assessment and Decision Analysis for Nanotechnology
I. Linkov (Intertox Inc)
|
